European stocks were largely flat on Wednesday due to losses in technology and mining sectors and as investors stayed on the sidelines ahead of the U.S. Federal Reserve’s policy ... Read More
AstraZeneca (AZN.L) took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion for the rights to Spanish ... Read More
Britain’s highest-profile fund manager, Neil Woodford, has begun building a stake in AstraZeneca in a move that could scupper rival Pfizer’s chances of buying the pharmaceutical giant later this ... Read More
The US pharmaceutical seeking to acquire UK rival AstraZeneca represents a tax avoidance risk, according to the UK druggist’s chief executive Pascal Soriot. Pfizer, which has proposed a £63bn ... Read More
U.S. pharmaceuticals company Pfizer has augmented its attempt to buy AstraZeneca, the U.K.’s second-biggest drug maker, with a letter to Prime Minister David Cameron. The missive, as well as ... Read More
The board of pharmaceutical company AstraZeneca on Friday flatly rejected drug maker Pfizer’s sweetened takeover offer just hours after it was levelled, describing it as inadequate. Pfizer Inc., the ... Read More
We use cookies to improve your browsing experience on our website. To find out more, please read our Privacy Policy and Cookies Policy, been updated and became effective May 24, 2018.
By continuing to navigate our website without changing your cookies settings, or by clicking 'Ok', you hereby acknowledge and agree to OneStopBrokers use of cookies.OkRead more